There are probably many different ideas about what optimal treatment for childhood cancer should look like. How did you approach achieving an objective assessment?
We followed a multi-stage process. First, we systematically reviewed the scientific literature to see what has been published so far on quality criteria. We found 18 studies. Altogether, they listed around 200 different criteria, which we then consolidated into 90 overarching criteria. In a second step, we developed an online questionnaire and sent it to pediatric oncology representatives from 32 countries whose healthcare systems are comparable to Switzerland's. In this way, we learned that children’s cancer centers in about two-thirds of these countries follow either national or local quality criteria. In the responses, we also came across five additional criteria, which we included in our list. Finally, in a third step, we examined how relevant the various quality criteria are for medical professionals as well as for parents of children with cancer in Switzerland. Having parents with lived experience contribute their practical insights to the project was very important to us—they offered another valuable perspective.
How do the perspectives of professionals and families with lived experience differ?
We oncologists tend to focus on criteria related to treatment. These include, for example, minimizing infection rates in the venous catheters we place for chemotherapy. Or ensuring rapid initiation of antibiotic treatment when a child with a high fever arrives at the hospital. If the fever is caused by a bacterial infection, time is critical because the child’s immune system is weakened by chemotherapy and cannot fight the bacteria, the situation can quickly lead to fatal sepsis.
